{
    "2019-12-19": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Dow Jones Today: The Great Melt Up Continues",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "Great Melt Up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "PreMarket Prep Recap: Earnings Movers, Finding Sellers In Johnson & Johnson",
                "features": {
                    "keywords": [
                        "PreMarket",
                        "Earnings",
                        "Movers",
                        "Sellers",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Have Insiders Been Buying Johnson & Johnson (NYSE:JNJ) Shares?",
                "features": {
                    "keywords": [
                        "Insiders",
                        "Buying",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Johnson & Johnson to Participate in 38th Annual JP Morgan Health Care Conference",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "JP Morgan",
                        "Health Care Conference"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "J&J Stock Gets Another Thumbs Up. Analyst Says Legal Worries Are ‘Priced In.’",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stock",
                        "Thumbs Up",
                        "Legal Worries",
                        "Priced In"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Johnson & Johnson",
                        "Eli Lilly",
                        "PNC Financial",
                        "EOG Resources",
                        "Archer-Daniels-Midland"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance",
                        "energy",
                        "agriculture"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}